Summary
Ten patients with severe spasticity were evaluated according to a standardized protocol in order to be treated by intraspinal baclofen. Entry criteria in the protocol were the following: 1) Stable central nervous system lesion, 2) Severe spasticity and/or flexo-extensor spasms not controllable by oral treatment, 3) Normal CSF circulation and 4) Informed consent. All patients received a test dose of twenty-five micrograms of baclofen injected intrathecally. At intervals of at least one day, doses were increased in 10–25 microgram steps until total abolition of spontaneous spasms was achieved in complete spinal cord lesions. In patients with residual motor function, doses were titrated until the optimal dose was found that reduced spasms and enabled performance of maximum daily life activities according to the patient's neurological level.
In nine patients a multidose reservoir was implanted to deliver intrathecal baclofen. Effective dosage was 60±31 micrograms in the entire group. Ashworth score was reduced from 4.6±0.7 to 1.2±0.4 (mean±SD) (p<0.0001) and spasms from 3.2±0.8 to 0.2±0.4 (p<0.0001).
Follow-up of the nine patients in whom a reservoir was implanted has been 18±9 months. Initial dosage requirements and tolerance were significantly different in complete (Frankel's A grade) or incomplete lesions (Frankel's B, C and D grades). Complete spinal cord lesions required a greater initial dose (156±43) than incomplete lesions (44±24), these differences being statistically significant (Student's t-test, p<0.05). Tolerance was observed only in patients with complete motor and complete sensory lesions. In incomplete lesions, dose increase was insignificant.
Similar content being viewed by others
References
Davidoff RA (1985) Antispasticity drugs: mechanisms of action. Ann Neurol 17: 107–116
Dralle D, Müller H, Zierski J, Klug N (1985) Intrathecal baclofen for spasticity. Lancet 2: 1003
Erickson DL, Lo J, Michaelson M (1989) Control of intractable spasticity with intrathecal morphine sulfate. Neurosurgery 24: 236–238
Frankel HL, Hancock DO, Hyslop G, Melzak J, Michaelis LS, Ungar GH, Vernon JOS, Walsh JJ (1969) The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I. Paraplegia 5: 93–95
Gros C (1979) Spasticity — clinical classification and surgical treatment. In: Krayenbühl Het al (eds) Advances and technical standards in neurosurgery, vol 6. Springer, Wien New York, pp 55–97
Kerr DIB, Ong J, Prager RH (1987) Phaclofen: a peripheral and central baclofen antagonist. Brain Res 405: 150–154
Kroin JS, Penn RD, Bessinger RL, Arzbaecher RC (1984) Reduced spinal reflexes following intrathecal baclofen in the rabbit. Exp Brain Res 540: 191–194
Latash ML, Penn RD, Corcos DM, Gottlieb GL (1990) Effects of intrathecal baclofen on voluntary motor control in spastic paresis. J Neurosurg 72: 388–392
Lazorthes Y (1988) Chronic intrathecal administration of baclofen in treatment of severe spasticity. In: Müller Het al (eds) Local-spinal therapy of spasticity. Springer, Berlin Heidelberg New York Tokyo, pp 215–222
Lazorthes Y, Sallerin-Caute B, Verdie JC, Bastide R, Carillo JP (1990) Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 72: 393–402
Müller H, Zierski J (1988) Pumps in pharmacotherapy. In: Müller Het al (eds) Local-spinal therapy of spasticity. Springer, Berlin Heidelberg New York Tokyo, pp 97–123
Müller H, Zierski J, Dralle D, Borner U, Hoffmann O (1987) The effect of intrathecal baclofen on electrical muscle activity in spasticity. J Neurol 234: 348–352
Müller H, Zierski J, Dralle D, Hoffmann O, Michaelis G (1988) Intrathecal baclofen in spasticity. In: Müller Het al (eds) Local-spinal therapy of spasticity. Springer, Berlin Heidelberg New York Tokyo, pp 155–214
Müller H, Zierski J, Dralle D, Kaub D, Mutschier E (1988) Pharmacokinetics of intrathecal baclofen. In: Müller Het al (eds) Local-spinal therapy of spasticity. Springer, Berlin Heidelberg New York Tokyo, pp 223–226
Müller-Schwefe G (1988) Physostigmine reversal of baclofen-induced sedation. In: Müller Het al (eds) Local-spinal therapy of spasticity. Springer, Berlin Heidelberg New York Tokyo, pp 253
Müller-Schwefe G, Penn RD (1989) Physostigmine in the treatment of intrathecal baclofen overdose. J Neurosurg 71: 273–275
Ochs G, Struppler A, Meyerson BA, Linderoth B, Gybels J, Gardner BP, Teddy P, Jamous A, Weinmann P (1989) Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. J Neurol Neurosurg Psychiatry 52: 933–939
Penn RD (1988) Chronic intrathecal baclofen for severe rigidity and spasms. In: Müller Het al (eds) Local-spinal therapy of spasticity. Springer, Berlin New York Tokyo, pp 151–153
Penn RD (1988) Intrathecal baclofen for severe spasticity. Ann NY Acad Sci 531: 157–166
Penn RD, Kroin JS (1984) Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1: 1078
Penn RD, Kroin JS (1985) Continuous intrathecal baclofen for severe spasticity. Lancet 2: 125–127
Penn RD, Kroin JS (1987) Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg 66: 181–185
Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, Kroin JS (1989) Intrathecal baclofen for severe spinal spasticity. New Engl J Med 320: 1517–1521
Price GW, Wilkin GP, Turnbull MJ, Bowery NG (1984) Are baclofen-sensitive GABA-B receptors present on primary afferent terminals of the spinal cord? Nature 307: 71–74
Scott BA, Pulliam MW (1987) Management of spasticity and painful spasms in paraplegia. In: Tindall GT (ed) Contemporary Neurosurgery, vol 9, no 11. Williams and Wilkins, Baltimore
Zieglgänsberger W (1987) Dorsal horn neuropharmacology: Baclofen and morphine. Ann NY Acad Sci 531: 150–156
Zierski J, Müller H (1988) Implantation of ports and pumps. Technique for intrathecal administration of drugs. In: Müller Het al (eds) Local-spinal therapy of spasticity. Springer, Berlin Heidelberg New York Tokyo, pp 125–136
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sahuquillo, J., Muxi, T., Noguer, M. et al. Intraspinal baclofen in the treatment of severe spasticity and spasms. Acta neurochir 110, 166–173 (1991). https://doi.org/10.1007/BF01400686
Issue Date:
DOI: https://doi.org/10.1007/BF01400686